Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Analyze how volatility differs between index funds and bonds in retirement, and craft a plan that moderates swings while pursuing growth.
23,614 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Investors eye dividend income to replace a $70,000 salary. This piece breaks down three yield-based paths and the cap...
A once-overlooked dividend ETF is delivering double-digit gains this year, signaling a shift from megacap leadership ...
AI progress rests on more than cool gadgets. This infrastructure stock more sits at the backbone of data centers, clo...
Stellus Capital Investment Corp remains a high-yield option in private credit, yet recent earnings misses and a divid...
New 2026 guidance shows high earners with million+ 401(k)s can still build tax-free Roth assets through after-tax con...
As student debt relief conversations continue and markets wobble, families are exploring a dividend-driven approach t...
A closer look at JEPQ reveals a persistent gap between monthly income and total returns. The premium income ETF pays ...
SpaceX could redefine aerospace and energy, but investing in Elon Musk-backed ventures is no simple bet. This guide u...
As the 10-year Treasury sits in the low- to mid-4% zone, select dividend stocks more than keep pace with bond returns...
A multi trillion funding surge is intensifying the race to dominate AI, as tech giants and investors flood capital in...
As Kevin Warsh takes the helm, investors await his first Fed rate decision amid sticky inflation and a shifting economy.